Literature DB >> 27103167

Class IIa histone deacetylases affect neuronal remodeling and functional outcome after stroke.

Haifa Kassis1, Amjad Shehadah1, Chao Li1, Yi Zhang1, Yisheng Cui1, Cynthia Roberts1, Neema Sadry1, Xianshuang Liu1, Michael Chopp2, Zheng Gang Zhang3.   

Abstract

We have previously demonstrated that stroke induces nuclear shuttling of class IIa histone deacetylase 4 (HDAC4). Stroke-induced nuclear shuttling of HDAC4 is positively and significantly correlated with improved indices of neuronal remodeling in the peri-infarct cortex. In this study, using a rat model for middle cerebral artery occlusion (MCAO), we tested the effects of selective inhibition of class IIa HDACs on functional recovery and neuronal remodeling when administered 24hr after stroke. Adult male Wistar rats (n = 15-17/group) were subjected to 2 h MCAO and orally gavaged with MC1568 (a selective class IIa HDAC inhibitor), SAHA (a non-selective HDAC inhibitor), or vehicle-control for 7 days starting 24 h after MCAO. A battery of behavioral tests was performed. Lesion volume measurement and immunohistochemistry were performed 28 days after MCAO. We found that stroke increased total HDAC activity in the ipsilateral hemisphere compared to the contralateral hemisphere. Stroke-increased HDAC activity was significantly decreased by the administration of SAHA as well as by MC1568. However, SAHA significantly improved functional outcome compared to vehicle control, whereas selective class IIa inhibition with MC1568 increased mortality and lesion volume and did not improve functional outcome. In addition, MC1568 decreased microtubule associated protein 2 (MAP2, dendrites), phosphorylated neurofilament heavy chain (pNFH, axons) and myelin basic protein (MBP, myelination) immunoreactivity in the peri-infarct cortex. Quantitative RT-PCR of cortical neurons isolated by laser capture microdissection revealed that MC1568, but not SAHA, downregulated CREB and c-fos expression. Additionally, MC1568 decreased the expression of phosphorylated CREB (active) in neurons. Taken together, these findings demonstrate that selective inhibition of class IIa HDACs impairs neuronal remodeling and neurological outcome. Inactivation of CREB and c-fos by MC1568 likely contributes to this detrimental effect.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epigenetics; Neuronal repair; Stroke

Mesh:

Substances:

Year:  2016        PMID: 27103167      PMCID: PMC4860113          DOI: 10.1016/j.neuint.2016.04.006

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  46 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  A semiautomated method for measuring brain infarct volume.

Authors:  R A Swanson; M T Morton; G Tsao-Wu; R A Savalos; C Davidson; F R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  1990-03       Impact factor: 6.200

3.  New patterns of intracortical projections after focal cortical stroke.

Authors:  S T Carmichael; L Wei; C M Rovainen; T A Woolsey
Journal:  Neurobiol Dis       Date:  2001-10       Impact factor: 5.996

Review 4.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

5.  Long-term disability after first-ever stroke and related prognostic factors in the Perth Community Stroke Study, 1989-1990.

Authors:  Graeme J Hankey; Konrad Jamrozik; Robyn J Broadhurst; Susanne Forbes; Craig S Anderson
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

6.  Sodium 4-phenylbutyrate protects against cerebral ischemic injury.

Authors:  Xin Qi; Toru Hosoi; Yasunobu Okuma; Masayuki Kaneko; Yasuyuki Nomura
Journal:  Mol Pharmacol       Date:  2004-06-29       Impact factor: 4.436

7.  Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction.

Authors:  Ming Ren; Yan Leng; MiRa Jeong; Peter R Leeds; De-Maw Chuang
Journal:  J Neurochem       Date:  2004-06       Impact factor: 5.372

8.  Olig1 Acetylation and Nuclear Export Mediate Oligodendrocyte Development.

Authors:  Jinxiang Dai; Kathryn K Bercury; Weilin Jin; Wendy B Macklin
Journal:  J Neurosci       Date:  2015-12-02       Impact factor: 6.167

9.  CRE-mediated gene transcription in the peri-infarct area after focal cerebral ischemia in mice.

Authors:  Shiro Sugiura; Kazuo Kitagawa; Emi Omura-Matsuoka; Tsutomu Sasaki; Shigeru Tanaka; Yoshiki Yagita; Kohji Matsushita; Daniel R Storm; Masatsugu Hori
Journal:  J Neurosci Res       Date:  2004-02-01       Impact factor: 4.164

10.  Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery.

Authors:  Y Li; J Chen; X G Chen; L Wang; S C Gautam; Y X Xu; M Katakowski; L J Zhang; M Lu; N Janakiraman; M Chopp
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

View more
  19 in total

Review 1.  Sex differences in the brain: Implications for behavioral and biomedical research.

Authors:  Elena Choleris; Liisa A M Galea; Farida Sohrabji; Karyn M Frick
Journal:  Neurosci Biobehav Rev       Date:  2018-02       Impact factor: 8.989

2.  HDAC4 and HDAC5 form a complex with DREAM that epigenetically down-regulates NCX3 gene and its pharmacological inhibition reduces neuronal stroke damage.

Authors:  Luigi Formisano; Giusy Laudati; Natascia Guida; Luigi Mascolo; Angelo Serani; Ornella Cuomo; Maria Cantile; Francesca Boscia; Pasquale Molinaro; Serenella Anzilotti; Vincenzo Pizzorusso; Gianfranco Di Renzo; Giuseppe Pignataro; Lucio Annunziato
Journal:  J Cereb Blood Flow Metab       Date:  2019-11-07       Impact factor: 6.200

Review 3.  Complex neuroprotective and neurotoxic effects of histone deacetylases.

Authors:  Elizabeth A Thomas; Santosh R D'Mello
Journal:  J Neurochem       Date:  2018-04-06       Impact factor: 5.372

Review 4.  Epigenetic mechanisms and potential therapeutic targets in stroke.

Authors:  Kahlilia C Morris-Blanco; Anil K Chokkalla; Vijay Arruri; Soomin Jeong; Samantha M Probelsky; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2022-07-19       Impact factor: 6.960

Review 5.  Stroke and Etiopathogenesis: What Is Known?

Authors:  Tiziana Ciarambino; Pietro Crispino; Erika Mastrolorenzo; Antonello Viceconti; Mauro Giordano
Journal:  Genes (Basel)       Date:  2022-05-30       Impact factor: 4.141

6.  Role of microRNA-126 in vascular cognitive impairment in mice.

Authors:  Peng Yu; Poornima Venkat; Michael Chopp; Alex Zacharek; Yi Shen; Ruizhuo Ning; Linlin Liang; Wei Li; Li Zhang; Julie Landschoot-Ward; RongCai Jiang; Jieli Chen
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-14       Impact factor: 6.200

7.  The Effect of Histone Deacetylase Inhibitors Panobinostat or Entinostat on Motor Recovery in Mice After Ischemic Stroke.

Authors:  Abdullah Al Shoyaib; Faisal F Alamri; Nausheen Syeara; Srinidhi Jayaraman; Serob T Karamyan; Thiruma V Arumugam; Vardan T Karamyan
Journal:  Neuromolecular Med       Date:  2021-02-15       Impact factor: 3.843

8.  HDAC9 Polymorphism Alters Blood Gene Expression in Patients with Large Vessel Atherosclerotic Stroke.

Authors:  Natasha Shroff; Bradley P Ander; Xinhua Zhan; Boryana Stamova; DaZhi Liu; Heather Hull; Farah R Hamade; Cheryl Dykstra-Aiello; Kwan Ng; Frank R Sharp; Glen C Jickling
Journal:  Transl Stroke Res       Date:  2018-04-13       Impact factor: 6.800

Review 9.  Epigenetics in Stroke Recovery.

Authors:  Haifa Kassis; Amjad Shehadah; Michael Chopp; Zheng Gang Zhang
Journal:  Genes (Basel)       Date:  2017-02-27       Impact factor: 4.096

10.  Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke.

Authors:  Ying Tang; Yu-Hui Lin; Huan-Yu Ni; Jian Dong; Hong-Jin Yuan; Yu Zhang; Hai-Ying Liang; Meng-Cheng Yao; Qi-Gang Zhou; Hai-Yin Wu; Lei Chang; Chun-Xia Luo; Dong-Ya Zhu
Journal:  J Am Heart Assoc       Date:  2017-10-05       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.